📰 Given Marimed News
Page 3 - Given Marimed News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Marimed. Real-time updates on events, politics, business and more.
May 21, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it compare to its rivals? We will compare MariMed to similar companies based on the strength of its risk, analyst recommendations, valuation, earnings, profitability, dividends and institutional ownership. Volatility and Risk MariMed has a beta […]
May 16, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it weigh in compared to its competitors? We will compare MariMed to related companies based on the strength of its risk, institutional ownership, dividends, valuation, profitability, analyst recommendations and earnings. Earnings and Valuation This table […]
May 16, 2022
MariMed (OTCMKTS:MRMD – Get Rating) is one of 49 public companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare MariMed to related businesses based on the strength of its earnings, profitability, institutional ownership, risk, analyst recommendations, valuation and dividends. Profitability This table compares MariMed and its […]
March 20, 2022
MariMed (OTCMKTS:MRMD – Get Rating) and Zynga (NASDAQ:ZNGA – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability. Profitability This table compares MariMed and Zynga’s net margins, return on equity […]
March 16, 2022
Shutterstock (NYSE:SSTK – Get Rating) and MariMed (OTCMKTS:MRMD – Get Rating) are both computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, institutional ownership, dividends and analyst recommendations. Analyst Ratings This is a summary of current ratings for […]